The Medical Imaging & Technology Alliance (MITA) has issued a statement in support of the recently passed federal requirement that all mammography providers must include information about breast density in reports sent to patients and their physicians.
The FDA has published a statement emphasizing that thermography is not cleared as an alternative to mammography for breast cancer screening or diagnosis. This comes on the heels of the agency sending La Mesa, California-based Total Thermal Imaging a warning letter for marketing "an unapproved thermography device as a sole screening device for breast cancer and other diseases.”
At an academic health system in Boston, referring physicians have been ordering more breast MRI scans since Massachusetts mandated that mammographers inform patients in writing of their breast density.
The Radiology Business Management Association (RBMA) and Ultrasound Access Coalition (UAC) have released a statement highlighting their opposition to the $112 million in Medicare ultrasound reimbursement cuts planned by CMS.
The Royal Australian and New Zealand College of Radiologists (RANZCR) announced Thursday, Feb. 21, that it has published a draft of its guidelines for the appropriate use of AI and machine learning (ML) in healthcare.
Joseph J. Cappello, executive director of Are You Dense and Are You Dense Advocacy, spoke to Radiology Business about how it felt to finally see federal breast density notification requirements signed into law.
The American College of Radiology (ACR) has asked radiologists and other healthcare professionals to send them invoices that reflect the real-world costs associated with purchasing ultrasound equipment.
When President Donald Trump signed a federal funding bill into law on Feb. 15, it included text that said that all mammography providers must include updated information about breast density in reports sent to both patients and their physicians.
Genetic testing should be available for all breast cancer patients to determine hereditary risk in addition to standard imaging exams, according to new guidelines published Feb. 14 by The American Society of Breast Surgeons.
More consistent follow-up protocols after benign concordant MRI-guided percutaneous core needle biopsies (MR-PCNBs) could lead to better overall patient care, according to a case study published in the Journal of the American College of Radiology.